Wearable devices enable remote heart failure drug trials in 2036
Researchers in 2036 distributed wearable technology to 200 volunteers for a randomized clinical trial on heart failure prevention.
Real-time data guides personalized dosing
Participants wore devices that tracked heart rate, blood pressure, hormone levels and activity. Artificial-intelligence tools processed this information to adjust drug doses for each individual based on real-time metrics.
Virtual assistants explain results clearly
Interactive virtual health-care assistants provided participants with clear explanations of their personal results. These tools helped clean the collected data and supported the selection of the study cohort.
Remote trials reduce dropout rates
Prachi Desai states that empowering patients to conduct trials in their own communities improves data quality. This approach also lowers dropout rates and achieves cost savings for the research program.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.